Found 11 Pneumonia trials
A listing of Pneumonia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Neuropsychiatric sequalae of COVID-19
The purpose of this study is to explore possible neurological complications resulting from prior COVID-19 infection. Neurological symptoms, including ‘brain fog’, depression, and/or anxiety can be disabling. This study aims to determine the prevalence and severity of these symptoms. Unfortunately, little is known about these neuropsychiatric symptoms, particularly in patients …
Neural and Motor Functional Changes in HIV and Stroke Before and After Robot-Assisted Neurorehabilitation
The purpose of this research study is twofold: to study the role HIV has on the brain’s function and more particularly, the relationship between HIV and stroke; and to study how the presence of HIV effects robot-assisted rehabilitation after stroke, and its association with clinical improvement.
Towards Objective Metrics to Quantify the Role of HIV and Increasing Cognitive Demand on Instrumental ADLs in People Aging with HIV
The objective of this proposal is to examine the utility of a robot-based approach to study instrumental activities of daily living (IADLs) function and cognitive-motor performance in persons aging with HIV. IADLs often require high levels of executive functioning during the performance of motor activities, but there are no good …
Cohort Study of Preclinical Pulmonary Fibrosis
The overall goal of the proposed research is to determine how common genetic variants and environmental risk factors predispose to the development, natural history, and phenotypic heterogeneity of idiopathic interstitial pneumonia (IIP) by establishing and prospectively evaluating a cohort of asymptomatic first-degree relatives of IIP cases.
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
A trial to compare different investigational agents for their ability to improve clinical outcomes n severely ill patients with COVID-19 pneumonia.
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV
Phase 3
The research study is being conducted to examine the effects of personalized smoking cessation medication treatment in order to help people with HIV/AIDS to quit smoking. During the study, participants will take either varenicline (brand name Chantix®) or use the nicotine patch, and they will receive smoking cessation therapy with …
ASSESSING THE HIV-1 VIRAL RESERVOIR IN TISSUE SAMPLES
Normal 0 false false false EN-US X-NONE X-NONE Treating HIV infection with antiretroviral therapy (ART) leads to control of the virus and improvement of the immune system, which is your body natural ability to fight diseases. HIV patients who are well controlled (undetectable HIV by blood tests) still have HIV …
A Phase 1 Study of IL-15 Superagonist (N-803) and Broadly Neutralizing Antibodies to Induce HIV-1 Control
Phase 1
This study will investigate whether N-803, a new experimental drug that stimulates the immune system, is safe and tolerable when given alone and in combination with two new experimental drugs that are antibodies (natural proteins that the body makes in response to an infection) to HIV (the virus that causes …
Trial to Evaluate a Modified Vaccine (Triplex ) in Adults with HIV-1 and CMV Who Are on Potent Combination ART with Conserved Immune Function
Phase 2
The purpose of this study is to see if an investigational vaccine for cytomegalovirus (CMV), called Triplex®, is safe when given to people with both Human Immunodeficiency Virus (HIV) and CMV.
1 - 10 of 11
- 1
- 2
